Detailansicht

Wissensnetz

Person

Marek Widera

Biologe

Name	Marek Widera
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. rer. nat. PD (Fachbereich Medizin der Goethe-Universität Frankfurt am Main) (2022)
Beruf	Biologe
Variante	Marek Lukas Widera (vollständiger Name)
Beziehung	Universitätsklinikum Essen. Institut für Virologie Universitätsklinikum Düsseldorf Virologie (Thema)
Datensatztyp	Person
GND-Nummer	1204669449
Datensatz-ID	1204669449
Beteiligt an alle anzeigen SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals The VBNC state : a fundamental survival strategy of Acinetobacter baumannii The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens Early detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German wastewater Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater Early detection of SARS-CoV-2 Omicron BA.4/5 in German wastewater Early detection of SARS-CoV-2 Omicron BA.4/5 in German wastewater Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach Wastewater surveillance allows early detection of SARS-CoV-2 omicron in North Rhine-Westphalia, Germany Wastewater surveillance allows early detection of SARS-CoV-2 omicron in North Rhine-Westphalia, Germany Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings Generation of a sleeping beauty transposon-based cellular system for rapid and sensitive screening for compounds and cellular factors limiting SARS-CoV-2 replication Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies Surveillance of SARS-CoV-2 in Frankfurt am Main from october to december 2020 reveals high viral diversity including spike mutation N501Y in B.1.1.70 and B.1.1.7 The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity A novel, broad-acting peptide inhibitor of double-stranded DNA virus gene expression and replication A novel, broad-acting peptide inhibitor of double-stranded DNA virus gene expression and replication Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020 Optimized qRT-PCR approach for the detection of intra- abd extra-cellular SARS-CoV-2 RNAs SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles Clinical and virological aspects of HBV reactivation: a focus on acute liver failure

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Marek Widera

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals

Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients

SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals

The VBNC state : a fundamental survival strategy of Acinetobacter baumannii

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens

Early detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German wastewater

Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater

Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater

Early detection of SARS-CoV-2 Omicron BA.4/5 in German wastewater

Early detection of SARS-CoV-2 Omicron BA.4/5 in German wastewater

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach

Wastewater surveillance allows early detection of SARS-CoV-2 omicron in North Rhine-Westphalia, Germany

Wastewater surveillance allows early detection of SARS-CoV-2 omicron in North Rhine-Westphalia, Germany

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings

Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q

Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q

Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings

Generation of a sleeping beauty transposon-based cellular system for rapid and sensitive screening for compounds and cellular factors limiting SARS-CoV-2 replication

Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection

Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies

Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies

Surveillance of SARS-CoV-2 in Frankfurt am Main from october to december 2020 reveals high viral diversity including spike mutation N501Y in B.1.1.70 and B.1.1.7

The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

A novel, broad-acting peptide inhibitor of double-stranded DNA virus gene expression and replication

A novel, broad-acting peptide inhibitor of double-stranded DNA virus gene expression and replication

Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020

Optimized qRT-PCR approach for the detection of intra- abd extra-cellular SARS-CoV-2 RNAs

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

Clinical and virological aspects of HBV reactivation: a focus on acute liver failure